MercadoLibre enters this week's close with a bruising 13% drop behind it and a fresh wave of analyst downgrades still landing — an unusually compressed reset for a stock whose long-run bulls have long priced perfection.
The Q1 earnings release on May 7 was the catalyst. The stock fell 11.3% the next session as margin compression from logistics and fintech investment spending came in worse than the Street had modelled. That single-day move set the tone for the week: MELI dropped 13.1% over the five days to $1,578.78, clawing back just 1.4% on Tuesday as the dust began to settle. The most recent comparable earnings shock — Q4 results reported in early May 2026 — produced a 1.8% decline followed by a 15.8% drop over five days, suggesting the market has form for treating MELI earnings events as multi-day re-rating processes rather than one-day events.
The analyst community has responded with broad, unanimous target cuts — but not capitulation. Every major firm that has moved since Thursday has lowered its number. Citi went furthest today, cutting to $1,950 and dropping its rating to Neutral from Buy, citing "continued margin compression amid the investment agenda." JPMorgan trimmed its Neutral target to $1,900. UBS cut to $1,750, staying Neutral. Morgan Stanley and Barclays both held Overweight ratings but pulled targets to $2,450 and $2,300 respectively — a signal that the bulls still see 45-55% upside at current prices but are unwilling to defend the old numbers. The consensus remains firmly Buy (15 buys, 4 holds), with the mean target at $2,252 — roughly 43% above Tuesday's close. The widening gap between price and target captures the debate precisely: the Street hasn't abandoned the MELI thesis, but margin timing has become the central argument. The bear case centres on an investment cycle that keeps EBITDA estimates moving lower even as revenue targets creep higher; the bull case counters that platform dominance across Latin American e-commerce and fintech makes the franchise nearly impossible to dislodge once the spend cycle turns. With a PE near 31x and EV/EBITDA at roughly 17-20x, the valuation has compressed meaningfully — the P/B ratio has fallen by more than one full turn over the past month — but the stock is still priced for a business expected to compound earnings at a high rate.
Short positioning offers little drama on its own, but the pattern is worth noting. Short interest is low at 1.9% of the free float, and borrow conditions are loose — cost to borrow is just 0.43%, and availability is wide. What is unusual is that short interest had been tracking lower through most of May before jumping 3.6% in a single session on Tuesday, taking it back near recent highs. That single-day tick higher, right after the stock recovered slightly, points to some marginal incremental bearish positioning in the wake of the Q1 miss. It is not crowding — it is more consistent with tactical hedging. Options positioning is similarly restrained: the put/call ratio at 0.93 is barely above its 20-day average of 0.92, with a z-score under 1. The ORTEX short score of 30.6 is consistent with light short-side pressure. Nothing in the lending or options market suggests a coordinated short attack.
One headline worth flagging: news reports today indicate that Michael Burry added MELI during the Q1 sell-off, a notable contrarian signal given the name's profile as a high-growth EM tech play now trading near a one-year low. Among existing institutional holders, Capital Research remains the largest owner at 11.4% and added over 500,000 shares as recently as April 30 — well before the Q1 print. Baillie Gifford, the Scottish long-term growth manager, holds 6.4% and has not sold. These are patient, growth-oriented holders less likely to rotate out on a single-quarter miss, which provides some structural support to the float.
The next earnings date is June 9 — less than four weeks away. With targets freshly reset and consensus still constructive, the focus will be on whether management can provide clearer guidance on the investment spend trajectory and the timing of margin recovery.
See the live data behind this article on ORTEX.
Open MELI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
